Taiwan FDA registration 5de94508f452f49e3827add0d9047c41
Retaining membrane
TW: 保視膜
Taiwan·Risk Class 2·BioTissue Holdings Inc.·Registered Mar 26, 2019 – Mar 26, 2029ActiveRegistration details
- Analysis ID
- 5de94508f452f49e3827add0d9047c41
- Customs Code
- DHA05603161003
Company information
- Manufacturer
- BioTissue Holdings Inc.
- Manufacturer Country
- United States
- Authorized Representative
- ORIENT EUROPHARMA CO., LTD.
Product details
- Intended Use
- This product can be used together to promote the healing of corneal conjunctival wounds or after the healing of infectious keratitis after surgery of general eyes, eyelids and eye sockets or in the acute and chronic stages of eye chemical burns. By covering the eyeball, this product provides a physical protection mechanism for the eyeball during the repair and restoration process.
- Product Type (Level 1)
- M Ophthalmology
- Import Information
- import
Dates and status
- Registration Date
- Mar 26, 2019
- Expiry Date
- Mar 26, 2029
About this record
Access comprehensive regulatory information for Retaining membrane in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5de94508f452f49e3827add0d9047c41 and manufactured by BioTissue Holdings Inc.. The authorized representative in Taiwan is ORIENT EUROPHARMA CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices